Lanzamiento de la Nueva Vacuna contra el COVID-19: Lo Que Necesitas Saber para el Otoño de 2024

Play Video

Los casos de COVID-19 están aumentando ligeramente en EE. UU., y se introducirá una nueva vacuna este otoño. Telemundo20 en Texas conversa con el Dr. Quay para discutir los datos más recientes sobre esta vacuna y las precauciones que las personas deben considerar para los próximos meses. A pesar de la presencia continua del virus, actualmente es menos infeccioso y se asemeja a un resfriado común en términos de transmisión.

New COVID-19 Vaccine Launch: What You Need to Know for Fall 2024

COVID-19 cases are rising slightly across the U.S., and a new vaccine will be introduced this fall. Telemundo20 in Texas talks with Dr. Quay to discuss the latest data on this vaccine and the precautions people should consider for the upcoming months. Despite the ongoing presence of the virus, it is currently less infectious and resembles a common cold in terms of transmission.

Steven Quay is the founder of Seattle-based Atossa Therapeutics Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other breast conditions.

He received his M.D. and Ph.D. from The University of Michigan, was a postdoctoral fellow at MIT with Nobel Laureate H. Gobind Khorana, a resident at the Harvard-MGH Hospital, and was on the faculty of Stanford University School of Medicine. His contributions to medicine have been cited over 9,600 times. He has founded six startups, invented seven FDA-approved pharmaceuticals, and holds 87 US patents. Over 80 million people have benefited from the medicines he invented.

His current passion is the prevention of the two million yearly breast cancer cases worldwide.

Related Content

Dr. Steven Quay is joined by Senator Rand Paul and Richard H. Ebright, Board of Governors professor of chemistry and chemical biology at Rutgers University. They discuss the lab leak theory of COVID-19 in detail.

Dr. Steven Quay testified to the Senate that the coronavirus came from a lab in Wuhan, China. His reasons include the timing of the virus's emergence, research activities at the Wuhan Institute of Virology, and the genomic sequence of the virus. Quay also criticized China's concealment of information and expressed concerns about risky research at the lab.